Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients.
about
Biomolecular markers in assessment and treatment of asthmaEvaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study.The inflammatory actions of coagulant and fibrinolytic proteases in disease.Regulation of airway contractility by plasminogen activators through N-methyl-D-aspartate receptor-1.Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling.Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2.
P2860
Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Plasminogen activator inhibito ...... m of allergic asthma patients.
@en
type
label
Plasminogen activator inhibito ...... m of allergic asthma patients.
@en
prefLabel
Plasminogen activator inhibito ...... m of allergic asthma patients.
@en
P50
P1476
Plasminogen activator inhibito ...... um of allergic asthma patients
@en
P2093
Sebastian Zukowski
P304
P356
10.2478/V10042-008-0029-0
P577
2008-01-01T00:00:00Z